|
Date: 18 April 2023 (Tuesday)
Time: 11am-12pm Venue: Theatrette 2, Level 2M, Matrix Building, 30 Biopolis Street, S138671 Format: In-person Hosted by: Adrian TEO, IMCB, Singapore |
|
Speaker's information
Mark MUTHIAH National University Health System "Linking clinicians and scientists to tackle metabolic diseases - the view from the liver" |
|
ABSTRACT
Fatty liver is a silent epidemic affecting 40% of the South East Asian population, which can drive liver related mortality as well as cardiovascular mortality. In this session, we will talk about how clinicians and scientists overcame challenges to work together to try to tackle this disease which is still not yet well understood. In particular, we will focus on the close communication required to select and optimize appropriate in vivo and in vitro systems to model NAFLD.
BIO
Mark Muthiah has a keen interest in liver transplantation and is currently the Medical Director of the Liver Transplantation Programme in NUH. His other clinical interests include non-alcoholic fatty liver disease, end stage liver failure, and endoscopic mucosal resection of colon polyps. Dr Muthiah’s research interest is in the interplay of cardiometabolic diseases and the liver, and he has published extensively on the topic. He is also actively involved in medical education and has received numerous teaching awards from the university. Despite his active involvement in research and education, he runs a busy clinical practice, and holds fast to the belief that excellence in medical research and education can only be borne out passion for clinical medicine.
Fatty liver is a silent epidemic affecting 40% of the South East Asian population, which can drive liver related mortality as well as cardiovascular mortality. In this session, we will talk about how clinicians and scientists overcame challenges to work together to try to tackle this disease which is still not yet well understood. In particular, we will focus on the close communication required to select and optimize appropriate in vivo and in vitro systems to model NAFLD.
BIO
Mark Muthiah has a keen interest in liver transplantation and is currently the Medical Director of the Liver Transplantation Programme in NUH. His other clinical interests include non-alcoholic fatty liver disease, end stage liver failure, and endoscopic mucosal resection of colon polyps. Dr Muthiah’s research interest is in the interplay of cardiometabolic diseases and the liver, and he has published extensively on the topic. He is also actively involved in medical education and has received numerous teaching awards from the university. Despite his active involvement in research and education, he runs a busy clinical practice, and holds fast to the belief that excellence in medical research and education can only be borne out passion for clinical medicine.